Detailed answers about BSMFT - THE BRITISH SOCIETY OF MYOFUNCTIONAL THERAPY, including incorporation, status, business activity, and accounts information.
When was BSMFT - THE BRITISH SOCIETY OF MYOFUNCTIONAL THERAPY founded?
BSMFT - THE BRITISH SOCIETY OF MYOFUNCTIONAL THERAPY was officially incorporated on 6 December 2020 and is registered under company number 13064218. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is BSMFT - THE BRITISH SOCIETY OF MYOFUNCTIONAL THERAPY?
PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of BSMFT - THE BRITISH SOCIETY OF MYOFUNCTIONAL THERAPY?
BSMFT - THE BRITISH SOCIETY OF MYOFUNCTIONAL THERAPY's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does BSMFT - THE BRITISH SOCIETY OF MYOFUNCTIONAL THERAPY do?
BSMFT - THE BRITISH SOCIETY OF MYOFUNCTIONAL THERAPY operates in the following sector: 85590 - Other education n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is BSMFT - THE BRITISH SOCIETY OF MYOFUNCTIONAL THERAPY's registered address?
The registered office address of BSMFT - THE BRITISH SOCIETY OF MYOFUNCTIONAL THERAPY is 71-75 SHELTON STREET, COVENT GARDEN, LONDON, UNITED KINGDOM, WC2H 9JQ. This is the official address filed with Companies House for legal and statutory correspondence.
Is BSMFT - THE BRITISH SOCIETY OF MYOFUNCTIONAL THERAPY financially stable?
The most recent accounts for BSMFT - THE BRITISH SOCIETY OF MYOFUNCTIONAL THERAPY were made up to 31 December 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 30 September 2026.